In the final end, the team unearthed no clear evidence highlighting a link between higher levels of saturated fat and a higher risk for dying from any cause. Similarly, no link was found between saturated fat and an increased risk for stroke, type 2 diabetes, and/or cardiovascular disease. Having said that, investigators cautioned a lack of sufficient evidence meant that they cannot rule out the possibility that saturated fat does contribute to a higher risk of dying early from cardiovascular disease.For further information www please visit.amsbio.com/MitoXpress-and-pH-Xtra.aspx or get in touch with AMSBIO on on+44-1235-828200 / +1-800-987-0985 or email. Founded in 1987, AMS Biotechnology is recognized today as a leading company adding to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and advancement in the medical, diet, cosmetics and energy industries. The AMSBIO range includes professional antibodies, peptides and recombinant proteins.